• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植受者中通过高分辨率TCR-β测序确定的T细胞克隆动力学
Biol Blood Marrow Transplant. 2020 Sep;26(9):1567-1574. doi: 10.1016/j.bbmt.2020.04.026. Epub 2020 May 15.
2
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
3
Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.供者 T 细胞受体谱在受者淋巴和实质器官中的分析揭示了骨髓移植后小鼠 GVHD 的克隆发病机制。
Front Immunol. 2021 Dec 7;12:778996. doi: 10.3389/fimmu.2021.778996. eCollection 2021.
4
Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.KIR基因型的供受者匹配可减少慢性移植物抗宿主病,且缺乏抑制性KIR配体可预防清髓性、HLA匹配的造血细胞移植后的复发。
PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.
5
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.使用白消安、氟达拉滨和抗胸腺细胞球蛋白进行减低强度预处理用于缓解期急性髓系白血病患者接受无关或单倍体相合家庭供者造血细胞移植
Biol Blood Marrow Transplant. 2017 Sep;23(9):1555-1566. doi: 10.1016/j.bbmt.2017.05.025. Epub 2017 May 25.
6
Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后T细胞受体Vβ基因谱的变化。
Chin Med J (Engl). 2004 Mar;117(3):413-8.
7
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.低剂量抗胸腺细胞球蛋白预防亲缘全相合异基因造血干细胞移植后移植物抗宿主病
Biol Blood Marrow Transplant. 2017 Dec;23(12):2096-2101. doi: 10.1016/j.bbmt.2017.08.007. Epub 2017 Aug 15.
8
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.延长 CCR5 阻断预防移植物抗宿主病可改善降低强度无关供者造血细胞移植的结局:一项 II 期临床试验。
Biol Blood Marrow Transplant. 2019 Mar;25(3):515-521. doi: 10.1016/j.bbmt.2018.09.034. Epub 2018 Oct 10.
9
Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.儿科血液恶性肿瘤患者 TCRαβ/CD19 耗竭的造血细胞移植后的免疫重建。
Transplant Cell Ther. 2021 Feb;27(2):169.e1-169.e9. doi: 10.1016/j.jtct.2020.10.006. Epub 2020 Dec 10.
10
Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.小鼠造血细胞移植后肠道中受体特异性T细胞库的重建
Blood Adv. 2020 Sep 8;4(17):4232-4243. doi: 10.1182/bloodadvances.2019000977.

引用本文的文献

1
Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non-T-Cell Depletion Protocols.采用不同非T细胞去除方案的单倍体造血干细胞移植后的免疫重建
MedComm (2020). 2025 May 19;6(6):e70206. doi: 10.1002/mco2.70206. eCollection 2025 Jun.
2
Long donor leukocyte telomeres raise risk of severe COVID-19 in recipients of allogeneic hematopoietic cell transplant.供体白细胞端粒较长会增加异基因造血细胞移植受者患重症 COVID-19 的风险。
Front Immunol. 2025 Apr 29;16:1524608. doi: 10.3389/fimmu.2025.1524608. eCollection 2025.
3
Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice.人源化小鼠实验性移植物抗宿主病的病理生理学及临床前相关性
Biomark Res. 2024 Nov 14;12(1):139. doi: 10.1186/s40364-024-00684-9.
4
Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后受者巨细胞病毒相关 T 细胞受体的研究进展。
Virol J. 2024 Sep 30;21(1):236. doi: 10.1186/s12985-024-02511-x.
5
NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation.自然杀伤细胞和 T 细胞受体库在异基因造血干细胞移植后早期建立,并受 CMV 再激活的影响。
Blood Adv. 2024 Nov 12;8(21):5612-5624. doi: 10.1182/bloodadvances.2024013117.
6
Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD.胃肠道活检中的多模态免疫细胞表型分析揭示了人类移植物抗宿主病中与微生物组相关的 T 细胞调节。
Cell Rep Med. 2023 Jul 18;4(7):101125. doi: 10.1016/j.xcrm.2023.101125.
7
Potential of TCR sequencing in graft-versus-host disease.TCR 测序在移植物抗宿主病中的应用潜力。
Bone Marrow Transplant. 2023 Mar;58(3):239-246. doi: 10.1038/s41409-022-01885-2. Epub 2022 Dec 7.
8
Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates.在免疫检查点抑制剂相关性免疫性肾炎患者的尿液中检测到与肾浸润 T 细胞克隆型相同的 T 细胞。
Oncoimmunology. 2022 Sep 22;11(1):2124678. doi: 10.1080/2162402X.2022.2124678. eCollection 2022.
9
Healthy-like CD4 Regulatory and CD4 Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.健康样 CD4 调节性和 CD4 常规 T 细胞受体库可预测供者淋巴细胞输注后移植物抗宿主病的保护作用。
Int J Mol Sci. 2022 Sep 18;23(18):10914. doi: 10.3390/ijms231810914.
10
Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG.CMV 再激活对 HCT 后急性髓系白血病复发的影响取决于疾病分期和 ATG。
Blood Adv. 2022 Jan 11;6(1):28-36. doi: 10.1182/bloodadvances.2021005509.

本文引用的文献

1
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后 1 年的 T 细胞受体遗传多样性。
Leukemia. 2020 May;34(5):1422-1432. doi: 10.1038/s41375-019-0654-y. Epub 2019 Nov 26.
2
T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.异基因骨髓移植后 T 细胞受体库的演变:组织学视角。
Biol Blood Marrow Transplant. 2019 May;25(5):868-882. doi: 10.1016/j.bbmt.2019.01.021. Epub 2019 Jan 21.
3
Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity.老年人巨细胞病毒暴露不会降低 CD8 T 细胞库多样性。
J Immunol. 2019 Jan 15;202(2):476-483. doi: 10.4049/jimmunol.1800217. Epub 2018 Dec 12.
4
T-cell receptor-α repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing.采用下一代测序技术对异基因干细胞移植后 CD8+T 细胞的 T 细胞受体-α 进行研究。
Haematologica. 2019 Mar;104(3):622-631. doi: 10.3324/haematol.2018.199802. Epub 2018 Sep 27.
5
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.移植后环磷酰胺治疗后T细胞库的起源与演变
JCI Insight. 2016;1(5). doi: 10.1172/jci.insight.86252. Epub 2016 Apr 21.
6
Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants.单倍体脐带血与匹配供体移植患者T细胞受体库的深度测序。
Chimerism. 2015 Jul 3;6(3):47-9. doi: 10.1080/19381956.2015.1128624. Epub 2016 Jan 8.
7
T-cell receptor profiling in cancer.癌症中的T细胞受体分析
Mol Oncol. 2015 Dec;9(10):2063-70. doi: 10.1016/j.molonc.2015.09.003. Epub 2015 Sep 15.
8
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.急性移植物抗宿主病临床数据收集的国际多中心标准化:西奈山急性移植物抗宿主病国际联盟报告
Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10. doi: 10.1016/j.bbmt.2015.09.001. Epub 2015 Sep 16.
9
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.异基因造血干细胞移植受者T细胞库的定量表征
Bone Marrow Transplant. 2015 Sep;50(9):1227-34. doi: 10.1038/bmt.2015.133. Epub 2015 Jun 8.
10
Dynamics of the cytotoxic T cell response to a model of acute viral infection.细胞毒性T细胞对急性病毒感染模型反应的动力学
J Virol. 2015 Apr;89(8):4517-26. doi: 10.1128/JVI.03474-14. Epub 2015 Feb 4.

异基因造血细胞移植受者中通过高分辨率TCR-β测序确定的T细胞克隆动力学

T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.

作者信息

Leick Mark, Gittelman Rachel M, Yusko Erik, Sanders Catherine, Robins Harlan, DeFilipp Zachariah, Nikiforow Sarah, Ritz Jerome, Chen Yi-Bin

机构信息

Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts.

Adaptive Biotechnologies, Seattle, Washington.

出版信息

Biol Blood Marrow Transplant. 2020 Sep;26(9):1567-1574. doi: 10.1016/j.bbmt.2020.04.026. Epub 2020 May 15.

DOI:10.1016/j.bbmt.2020.04.026
PMID:32417490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8279830/
Abstract

Delayed reconstitution of the immune system is a long-recognized complication after allogeneic hematopoietic cell transplantation (HCT). Specifically, loss of T cell diversity has been thought to contribute to infectious complications, graft-versus-host disease (GVHD), and disease relapse. We performed serial high-resolution next-generation sequencing of T cell receptor (TCR)-β in 99 related or unrelated donor (57 unrelated, 42 related) allogeneic HCT recipients (55 with reduced-intensity conditioning, 44 with myeloablative conditioning) during the first 3 months after HCT using the immunoSEQ Assay. We measured T cell fraction, clonality (1- Peilou's evenness) and Daley-Smith richness from recipient samples at multiple time points. In agreement with previous studies, we found that although absolute T cell numbers recover relatively quickly after HCT, T cell repertoire diversity remains diminished. Restricted diversity was associated with conditioning intensity, use of antithymocyte globulin, and donor type. Increased number of expanded clones compared to donor T cell clones at day +30 was associated with the incidence of acute GVHD (hazard ratio [HR], 1.11; P = .00005). Even after exclusion of the 12 patients who developed acute GVHD before day +30, the association between acute GVHD and increased clonal expansion at day +30 remained (HR, 1.098; P = .041), indicating that increased clonal T cell expansion preceded the development of acute GVHD. Our results highlight T cell clonal expansion as a potential novel biomarker for acute GVHD that warrants further study.

摘要

免疫系统重建延迟是异基因造血细胞移植(HCT)后长期公认的并发症。具体而言,T细胞多样性的丧失被认为会导致感染性并发症、移植物抗宿主病(GVHD)和疾病复发。我们使用免疫SEQ检测法,对99例相关或无关供体(57例无关供体,42例相关供体)的异基因HCT受者(55例接受减低强度预处理,44例接受清髓性预处理)在HCT后的前3个月进行了T细胞受体(TCR)-β的系列高分辨率下一代测序。我们在多个时间点测量了受者样本中的T细胞分数、克隆性(1 - 皮尔洛均匀度)和戴利 - 史密斯丰富度。与先前的研究一致,我们发现尽管HCT后绝对T细胞数量相对较快恢复,但T细胞库多样性仍然减少。受限的多样性与预处理强度、抗胸腺细胞球蛋白的使用和供体类型有关。与供体T细胞克隆相比,在第30天扩增克隆数量增加与急性GVHD的发生率相关(风险比[HR],1.11;P = 0.00005)。即使排除了在第30天之前发生急性GVHD的12例患者,急性GVHD与第30天克隆扩增增加之间的关联仍然存在(HR,1.098;P = 0.041),这表明克隆性T细胞扩增增加先于急性GVHD的发生。我们的结果突出了T细胞克隆扩增作为急性GVHD潜在的新型生物标志物,值得进一步研究。